arrow
D

David Pires

Universidade Católica Portuguesa
H-index:24
Citation Count:2,088
Views:0

Biography

No content for now.

Education

No content for now.

Work Experience

No content for now.

Honors & Awards

No content for now.

miR-21-5p dysregulation is associated with gut microbiota dysbiosis and pro-oncogenic markers in primary sclerosing cholangitis with concomitant inflammatory bowel disease

miR-21-5p表达异常与原发性硬化性胆管炎合并炎症性肠病中的肠道菌群失调和促癌标志物相关

2025-12-050
OAAI
Host-Directed Therapies Based on Protease Inhibitors to Control Mycobacterium tuberculosis and HIV Coinfection

基于蛋白酶抑制剂的宿主定向疗法以控制结核分枝杆菌和HIV合并感染

2025-04-300
OA
Synthesis, Activity, Toxicity, and In Silico Studies of New Antimycobacterial N-Alkyl Nitrobenzamides

新型抗分枝杆菌N-烷基硝基苯甲酰胺的合成,活性,毒性和计算机研究

2024-05-090
OAAI
Development of New Drugs to Treat Tuberculosis Based on the Dinitrobenzamide Scaffold
2024-04-271
OAAI
Unravelling the triad of neuroinvasion, neurodissemination, and neuroinflammation of human immunodeficiency virus type 1 in the central nervous system
2024-04-082
OA
Ethambutol and meropenem/clavulanate synergy promotes enhanced extracellular and intracellular killing of Mycobacterium tuberculosis
2024-04-033
OAAI
Human immunodeficiency virus transmission-Mechanisms underlying the cell-to-cell spread of human immunodeficiency virus
2023-09-123
PRE
Modulation of Cystatin F in Human Macrophages Impacts Cathepsin-Driven Killing of Multidrug-Resistant Mycobacterium tuberculosis
2023-07-244
OAAI
Cell-to-Cell Transmission of HIV-1 and HIV-2 from Infected Macrophages and Dendritic Cells to CD4+T Lymphocytes

从感染的巨噬细胞和树突状细胞到CD4 T淋巴细胞的HIV-1和HIV-2的细胞间传播

2023-04-225
OAAI
Development of Chitosan Particles Loaded with siRNA for Cystatin C to Control Intracellular Drug-Resistant Mycobacterium tuberculosis
2023-04-086
OA
Nitrobenzoates and Nitrothiobenzoates with Activity against M. tuberculosis
2023-04-085
OAAI
Insights into therapeutic liquid mixtures and formulations towards tuberculosis therapy
2023-04-012
OAAI
HIV/Mtb Co-Infection: From the Amplification of Disease Pathogenesis to an Emerging Syndemic
2023-03-2726
OAAI
Fluoroquinolone Derivatives in the Treatment of Mycobacterium tuberculosis Infection
2022-09-300
OAAI
Benzoic Acid Derivatives as Prodrugs for the Treatment of Tuberculosis
2022-09-076
OAAI
Uncovering Beta-Lactam Susceptibility Patterns in Clinical Isolates of Mycobacterium tuberculosis through Whole-Genome Sequencing
2022-08-319
OAAI
Spatial localization of cathepsins: Implications in immune activation and resolution during infections
2022-08-0316
OAAI
Modulation of Cystatin C in Human Macrophages Improves Anti-Mycobacterial Immune Responses to Mycobacterium tuberculosis Infection and Coinfection With HIV
2021-11-1815
OAAI
Repurposing Saquinavir for Host-Directed Therapy to Control Mycobacterium Tuberculosis Infection
2021-03-2622
OAAI